Liesbeth E. Bakker‐Jonges
About
In The Last Decade
Liesbeth E. Bakker‐Jonges
22 papers receiving 389 citations
Peers
Comparison fields: 5 of 62
- Rheumatology 175
- Immunology 161
- Radiology, Nuclear Medicine and Imaging 77
- Public Health, Environmental and Occupational Health 76
- Epidemiology 67
Countries citing papers authored by Liesbeth E. Bakker‐Jonges
This map shows the geographic impact of Liesbeth E. Bakker‐Jonges's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liesbeth E. Bakker‐Jonges with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liesbeth E. Bakker‐Jonges more than expected).
Fields of papers citing papers by Liesbeth E. Bakker‐Jonges
This network shows the impact of papers produced by Liesbeth E. Bakker‐Jonges. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liesbeth E. Bakker‐Jonges. The network helps show where Liesbeth E. Bakker‐Jonges may publish in the future.
Co-authorship network of co-authors of Liesbeth E. Bakker‐Jonges
This figure shows the co-authorship network connecting the top 25 collaborators of Liesbeth E. Bakker‐Jonges. A scholar is included among the top collaborators of Liesbeth E. Bakker‐Jonges based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liesbeth E. Bakker‐Jonges. Liesbeth E. Bakker‐Jonges is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 7 | |
| 3 | [Antinuclear antibodies in systemic autoimmune disease]. | 3 |
| 4 | 14 | |
| 5 | 9 | |
| 6 | 30 | |
| 7 | 21 | |
| 8 | 5 | |
| 9 | Towards a data-driven evaluation of the 2010 ACR/EULAR criteria for rheumatoid arthritis: Is it sensible to look at levels of rheumatoid factor? | 1 |
| 10 | 38 | |
| 11 | 25 | |
| 12 | Laboratory diagnosis of ANA, anti-dsDNA- and anti-ENA- antibodies; recommendations following the outcomes of a questionaire | 2 |
| 13 | Laboratoriumdiagnostiek van ANA, anti-ds-DNA- en anti-ENA-antistoffen: aanbevelingen naar aanleiding van een enquête | 3 |
| 14 | 75 | |
| 15 | 4 | |
| 16 | 18 | |
| 17 | 18 | |
| 18 | 44 | |
| 19 | [A retrospective study on the role of antibodies against soluble liver antigen (anti-SLA antibodies) and other autoantibodies in the diagnostics of autoimmune hepatitis]. | 1 |
| 20 | 57 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.